Loading stock data...
AbCellera Biologics Inc. (ABCL) Stock Price, Chart & Analysis
AbCellera Biologics Inc.ABCL
Market Closed$4.17
$-0.12-2.80%
ABCL Market Indicators
Very Bullish
Market Sentiment
Historical Price Chart
View the historical price chart for ABCL to analyze trends and spot opportunities. Use our interactive chart to compare past performance and make informed decisions.
AbCellera Biologics Inc. (ABCL)
Loading chart data...
Is AbCellera Biologics Inc. (ABCL) Stock a Buy in 2025?
YES
BUY
Score: 73/100
Yes, ABCL stock appears to be a good buy in 2025 based on our comprehensive analysis.
Comprehensive analysis of whether ABCL stock is a good investment in 2025, including growth drivers, valuation metrics, risk factors, and analyst recommendations.
Growth Drivers
- Healthcare sector momentum
Valuation Considerations
- Analyst price targets suggest 122.7% upside potential
Risk Factors
- High debt-to-equity ratio of 14.11
- Healthcare sector cyclicality
Analyst Consensus
Buy Ratings:8
Hold Ratings:1
Sell Ratings:1
Avg. Price Target:$9.29
Upside Potential:122.7%
Investment Summary
ABCL presents a mixed investment profile for 2025. The company shows strong growth drivers including healthcare sector momentum, though analyst price targets suggest 122.7% upside potential.
Analyst sentiment is generally positive with 8 buy ratings vs 1 sell ratings.
Investors should weigh the growth potential against the identified risks, particularly high debt-to-equity ratio of 14.11, and consider their own risk tolerance and investment timeline.
Final Recommendation
BUY
Recommendation Score
Overall Score:73/100
Buy
2030 Price Prediction
Predicted Price:$12.73
Potential Return:+205.3%
Key Factors
- Significantly declining revenue
- Very strong analyst buy consensus
- Very significant upside potential
- Exceptional long-term growth potential to 2030
- Wide analyst target range indicates uncertainty
- Debt-to-Market-Cap Ratio: 11.4% (Low)
Investment Decision
Based on our comprehensive analysis of ABCL's financial metrics, growth prospects, valuation, analyst sentiment, and risk factors, we recommend a BUY. This recommendation considers the company's current fundamentals, market position, and future growth potential while accounting for identified risks and market conditions.
abcl Stock Price Prediction 2030
Predicted 2030 Price
$12.73
+205.3%from current price
Based on revenue growth analysis and market trends, abcl stock is projected to reach $12.73 by 2030, representing a 205.3% increase from the current price of $4.17.
Current Price
$4.17
Revenue Growth
133.3%
Analyst Target
$9.29
View Full Prediction Analysis
Get detailed analyst targets, key factors, and comprehensive forecast analysis
How to Invest in abcl Stock?
Quick Investment Insights for abcl
Low Volatility (Beta: 0.65)
1. Research Fundamentals
Analyze financial statements and market position
2. Technical Analysis
Review price charts and technical indicators
3. Risk Assessment
Evaluate market and company-specific risks
Company Profile
AbCellera Biologics Inc.
Healthcare
Biotechnology
AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its product pipeline includes ABCL635, an antibody...
Employees
596
Market Cap
$1.25B